Compare PRAX & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | CRUS |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | United States | United States |
| Employees | N/A | 1668 |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.6B |
| IPO Year | 2020 | 1997 |
| Metric | PRAX | CRUS |
|---|---|---|
| Price | $322.54 | $150.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 5 |
| Target Price | ★ $572.13 | $157.00 |
| AVG Volume (30 Days) | ★ 548.0K | 531.6K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.83 |
| EPS | N/A | ★ 7.85 |
| Revenue | N/A | ★ $1,997,379,000.00 |
| Revenue This Year | N/A | $7.12 |
| Revenue Next Year | $7,758.26 | $0.49 |
| P/E Ratio | ★ N/A | $19.10 |
| Revenue Growth | N/A | ★ 5.34 |
| 52 Week Low | $37.25 | $92.02 |
| 52 Week High | $366.52 | $180.42 |
| Indicator | PRAX | CRUS |
|---|---|---|
| Relative Strength Index (RSI) | 54.07 | 43.06 |
| Support Level | $282.49 | $139.43 |
| Resistance Level | $344.07 | $154.90 |
| Average True Range (ATR) | 21.29 | 4.86 |
| MACD | 2.92 | -0.13 |
| Stochastic Oscillator | 54.65 | 31.77 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Cirrus Logic Inc is a supplier of low-power, low-latency, high-precision audio components that are used in a variety of applications, including smartphones, PCs, tablets, AR/VR headsets, wearables, home theater systems, automotive entertainment systems, and professional audio systems. The firm's products are organized into two streams: audio products and HPMS Products. These products include amplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters, and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, India, South Korea, and countries across the world.